AMNEAL PHARMACEUTICALS, INC.: other nonoperating income or expense

What this measure means

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Exact concept: us-gaap:OtherNonoperatingIncomeExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2016-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• AMNEAL PHARMACEUTICALS, INC.: total assets
• AMNEAL PHARMACEUTICALS, INC.: stockholders equity
• AMNEAL PHARMACEUTICALS, INC.: cash and cash equivalents
• AMNEAL PHARMACEUTICALS, INC.: net income or loss
• AMNEAL PHARMACEUTICALS, INC.: operating cash flow
• AMNEAL PHARMACEUTICALS, INC.: capital expenditure payments
• AMNEAL PHARMACEUTICALS, INC.: contract revenue excluding tax
• AMNEAL PHARMACEUTICALS, INC.: financing cash flow
• AMNEAL PHARMACEUTICALS, INC.: investing cash flow
• AMNEAL PHARMACEUTICALS, INC.: retained earnings or deficit
• AMNEAL PHARMACEUTICALS, INC.: basic weighted-average shares
• AMNEAL PHARMACEUTICALS, INC.: diluted weighted-average shares
• AMNEAL PHARMACEUTICALS, INC.: basic earnings per share
• AMNEAL PHARMACEUTICALS, INC.: diluted earnings per share
• AMNEAL PHARMACEUTICALS, INC.: income tax expense or benefit
• AMNEAL PHARMACEUTICALS, INC.: net property, plant and equipment
• AMNEAL PHARMACEUTICALS, INC.: share-based compensation expense
• AMNEAL PHARMACEUTICALS, INC.: operating income or loss
• AMNEAL PHARMACEUTICALS, INC.: current assets
• AMNEAL PHARMACEUTICALS, INC.: current liabilities
• AMNEAL PHARMACEUTICALS, INC.: current accounts payable
• AMNEAL PHARMACEUTICALS, INC.: goodwill carrying amount
• AMNEAL PHARMACEUTICALS, INC.: net finite-lived intangible assets
• AMNEAL PHARMACEUTICALS, INC.: net current accounts receivable
• AMNEAL PHARMACEUTICALS, INC.: net inventory
• AMNEAL PHARMACEUTICALS, INC.: gross profit
• AMNEAL PHARMACEUTICALS, INC.: selling, general and administrative expense
• AMNEAL PHARMACEUTICALS, INC.: research and development expense
• AMNEAL PHARMACEUTICALS, INC.: cash including restricted cash
• AMNEAL PHARMACEUTICALS, INC.: additional paid-in capital
• AMNEAL PHARMACEUTICALS, INC.: accumulated other comprehensive income or loss
• AMNEAL PHARMACEUTICALS, INC.: total equity including noncontrolling interests
• AMNEAL PHARMACEUTICALS, INC.: operating lease right-of-use asset
• AMNEAL PHARMACEUTICALS, INC.: operating lease liability
• AMNEAL PHARMACEUTICALS, INC.: long-term debt
• AMNEAL PHARMACEUTICALS, INC.: gross property, plant and equipment
• AMNEAL PHARMACEUTICALS, INC.: accumulated depreciation on property, plant and equipment
• AMNEAL PHARMACEUTICALS, INC.: net intangible assets excluding goodwill
• AMNEAL PHARMACEUTICALS, INC.: other noncurrent assets
• AMNEAL PHARMACEUTICALS, INC.: other noncurrent liabilities
• AMNEAL PHARMACEUTICALS, INC.: prepaid expenses and other current assets
• AMNEAL PHARMACEUTICALS, INC.: net deferred tax assets
• AMNEAL PHARMACEUTICALS, INC.: net deferred tax liabilities
• AMNEAL PHARMACEUTICALS, INC.: pre-tax income or loss from continuing operations
• AMNEAL PHARMACEUTICALS, INC.: profit or loss including noncontrolling interests
• AMNEAL PHARMACEUTICALS, INC.: comprehensive income or loss
• AMNEAL PHARMACEUTICALS, INC.: net income available to common stockholders
• AMNEAL PHARMACEUTICALS, INC.: depreciation expense
• AMNEAL PHARMACEUTICALS, INC.: amortization of intangible assets
• AMNEAL PHARMACEUTICALS, INC.: nonoperating income or expense
• AMNEAL PHARMACEUTICALS, INC.: current income tax expense or benefit
• AMNEAL PHARMACEUTICALS, INC.: deferred income tax expense or benefit
• AMNEAL PHARMACEUTICALS, INC.: interest paid, net
• AMNEAL PHARMACEUTICALS, INC.: income taxes paid, net
• AMNEAL PHARMACEUTICALS, INC.: operating lease payments
• AMNEAL PHARMACEUTICALS, INC.: change in accounts receivable
• AMNEAL PHARMACEUTICALS, INC.: change in inventories

Inspect the source

Entity

AMNEAL PHARMACEUTICALS, INC. / CIK 0001723128

Captured

2026-09-21T17:27:25.086Z

SEC response SHA-256

075c5a61ea16a3687086a44ded16226e03e05d8e3235bb2d57788b8b10d1e3fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001723128.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))